Double Blind Placebo Controlled Study of Lamictal in Acute Bipolar Depression

GlaxoSmithKline

Description

A Placebo Controlled Study Evaluating Efficacy and Safety of Medication in Patients with Bipolar Disorder

Citations (0)

Mentions (0)

Metrics

Dataset Index

0.2

FAIR Score

31%

Citations

0

Mentions

0

Metrics Over Time

Publication Details

DOI

Publisher

Vivli

License

Study data may be accessed by completing a request form at https://vivli.org. It will then be reviewed according to the data contributor’s governance policy, see https://vivli.org/members/ourmembers/ for Vivli member’s review process. If approved, use of the data is governed by the data use agreement at https://vivli.org/resources/vivli-data-use-agreement/

Assigned Domain

Subfield

Psychiatry and Mental health

Field

Medicine

Domain

Health Sciences

Confidence Score

69%

Source

Scholar Data Model

Keywords

Conditions: Bipolar DisorderInterventions: lamotrigine

Normalization Factors

FT

57.69

CTw

1.00

MTw

1.00